Industry Symposia at TWC2026

The Industry Symposia at TWC2026 offer participating companies the opportunity to present their innovations, technologies, and clinical applications to an international audience of experts in theranostics and radiomolecular precision medicine.

These sessions are an integral part of the congress programme and provide valuable insights into translational research, case studies, and future directions from the industry’s perspective.

A detailed overview of all confirmed industry symposia will be published here closer to the congress.

Friday, January 30, 2026

BEYOND LUTETIUM - UNLOCKING THE POWER OF NOVEL RADIOISOTOPES

  • Chiara Maria Grana (Italy)

Changing the Care Paradigm

Emerging radiopharmaceuticals and novel therapies are increasing the demand for molecular imaging. Simultaneously, advancements in hybrid imaging are unlocking new levels of possibility.

Join us for a talk highlighting how one clinical team is leveraging the latest developments in molecular imaging to reimagine its approach to patient care.

  • Tim Lagana & Ward Digby

Saturday, January 31, 2026

INTRODUCTION

  • Oliver Sartor (USA)
    WHY NEXT-GENERATION PSMA ARE NEEDED?

ROUND TABLE : DESIGNING THE NEXT ERA OF PSMA-TARGETING THERAPY

  • Jeremie Calais (USA, France)
    HOW NEW PSMA RADIOPHARMACEUTICALS GENERATION CAN TACKLE UNMET NEEDS
  • Yehia Omar (Egypt)
    THE EXPERIENCE OF A NEW PSMA TARGETED RADIOLABELED PEPTIDE
  • Mike Sathekge (South Africa)
    BRIDGING THE GLOBAL ACCESS GAP IN PSMA IMAGING AND THERAPY
  • all
    DISCUSSION

CONCLUSION

  • Oliver Sartor (USA)
    SHAPING THE NEXT DECADE OF RADIOLIGAND THERAPY IN PROSTATE CANCER

Sunday, February 1, 2026

Unlocking the Potential of Theranostics Through Strategic Innovation

  • Dr. Vladimir Cmiljanovic, CEO Swiss Rockets AG

SCALING THERANOSTICS FOR EVERY PATIENT, EVERYWHERE. GROUND-BREAKING TECHNOLOGIES FOR INNOVATIVE PATIENT CARE.

  • Sergio Calvo (Global GM, Theranostics, GE HealthCare)
  • Andrei Iagaru (Professor, Stanford University Medical Center)
  • Ilya Gipp (Chief Medical Officer – Oncology, GE HealthCare)

The detailed session content will be announced soon.

Precision Revolution: See More to Accelerate the Cure for All.

Chair: Chao Wang (China)

  • Chao Wang (President, Molecular Imaging Business Unit, United Imaging Healthcare)
    WELCOME & INTRODUCTION
  • Kgomotso Mokoala (Associate Professor and the Head of Clinical Unit in the Department of Nuclear Medicine at the University of Pretoria and Steve Biko Academic Hospital and Immediate Past President of the SASNM)
    THE EMERGING ROLE OF DIGITAL PET AND ARTIFICIAL INTELLIGENCE IN GYNAECOLOGICAL ONCOLOGY
  • Hongcheng Shi (Director of the Department of Nuclear Medicine at Zhongshan Hospital, affiliated with Fudan University)
    DUAL-TRACER PET: THE MULTI-DIMENSIONAL LENS ON DISEASE

RADIOLIGAND THERAPY: INDUSTRY PERSPECTIVES AND OUTLOOK

  • Daniela Niepel (Advanced Accelerator Applications, a Novartis company)

Contact

For questions regarding your booking or if you are interested in presenting your company at the 8th Theranostics World Congress, please contact us.

Coordination of Exhibitors and Sponsors
Brandon Bernack
E-Mail: brandon.bernack@kukm.de